Cita APA (7a ed.)

Sougawa, N., Miyagawa, S., Fukushima, S., Kawamura, A., Yokoyama, J., Ito, E., . . . Sawa, Y. (2018). Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy. Nature Portfolio.

Cita Chicago Style (17a ed.)

Sougawa, Nagako, et al. Immunologic Targeting of CD30 Eliminates Tumourigenic Human Pluripotent Stem Cells, Allowing Safer Clinical Application of HiPSC-based Cell Therapy. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Sougawa, Nagako, et al. Immunologic Targeting of CD30 Eliminates Tumourigenic Human Pluripotent Stem Cells, Allowing Safer Clinical Application of HiPSC-based Cell Therapy. Nature Portfolio, 2018.